[1]
K. Gordon, “Effect of Spesolimab on Achieving Sustained Disease Remission in Patients with Generalized Pustular Psoriasis: Results from the Effisayil 2 Study”,
J of Skin
, vol. 7, no. 6, p. s247, Nov. 2023.